# Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study

> **NCT06418750** · NA · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Myeloma Multiple

## Interventions

- **OTHER:** dermo-cosmetic product

## Key facts

- **NCT ID:** NCT06418750
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-04
- **Primary completion:** 2026-03-23
- **Final completion:** 2026-03-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418750, "Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06418750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*